Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...
Medtronic (MDT) ended the recent trading session at $90.19, demonstrating a +1.05% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.29%. Elsewhere, the ...
Medtronic PLC closed 3.70% below its 52-week high of $92.68, which the company achieved on October 24th.
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...
Abnormal Security names a new finance chief as it preps for an IPO, Birkenstock appoints a new CFO and Medtronic hires its ...
Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.
Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...
The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...
Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).